NVAX: Dana dhuwit saben saham Novavax Pharma

Simbol lan logo merek Novavax Pharma (NVAX)

A streamlined network of global carriers ensured uninterrupted deliveries, triggering a sharp rally on the chart. The cash per share metric confirms financial stability, while 3.80 determines the latest valuation figure. Novavax, Inc. (NVAX) maintains market confidence through its reputation as a creator of safe protein-based drugs, although its profitability depends on government contracts and seasonal spikes in disease incidence, creating volatility in results.

Novavax Pharma (NVAX): Dhuwit awis saben siji saham saka 04.07.2022 nganti 20.11.2026

Rincian metrik komprehensif lan analitis Novavax Inc (NVAX)

- rega lan prakiraan konsensus rega:
- informasi kapitalisasi pasar:
- data dhuwit lan arus kas:
Analisis komprehensif perusahaan:Novavax Corp NVAX
Barang unggulan Novavax

This indicator reflects the volume of liquid assets per common share by dividing the total cash balance by the number of outstanding securities. An analysis of cash per share allows for an assessment of the ability of Novavax, Inc. (NVAX) to fund costly R&D projects and retain highly qualified virologists, ensuring the stability of research-intensive recombinant vaccine development without resorting to external borrowing.